Inventiva reports preliminary 2024 fiscal year financial results¹ and provides a business update
Inventiva is a public company listed on compartment B of the regulated market of Euronext Paris (ticker: IVA, ISIN: FR0013233012) and on the NASDAQ Global Market in the United States (ticker: IVA). www.inventivapharma.com
Kadant Reports Fourth Quarter and Fiscal Year 2024 Results
WESTFORD, Mass., Feb. 12, 2025 (GLOBE NEWSWIRE) -- Kadant Inc. (NYSE: KAI) reported its financial results for the fourth quarter and fiscal year ended December 28, 2024. Gross margin was 43.4% GAAP EPS decreased 12% to $2.04 Adjusted EPS decreased 7% to $2.25 Adjusted EBITDA increased 8% to $52 million and represented 20.3% of revenue
Texas and Oklahoma — which joined the conference on July 1 — and slight increases in the amounts provided to the 14 incumbent ...
CEL-SCI Corporation (NYSE:CVM) reports fiscal year 2024 financial and operational results. The press release and Form 10-K filing encapsulate a year of preparation for confirmatory registration ...
GEE Group Inc. (NYSE American:JOB) together with its subsidiaries (collectively referred to as the “Company,” “GEE Group,” “our” or “we”), a provider of professional staffing services ...
The success reflects the robust performance of its subsidiaries, effective debt restructuring, and increased demand on its ...
IWATA, Japan-- ( BUSINESS WIRE )--Yamaha Motor Co., Ltd. (Tokyo: 7272) announces its consolidated business results for the ...
Mississippi State athletics operated at a deficit for the 2024 fiscal year, according to documents obtained by the Clarion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback